With NVIDIA (NASDAQ:NVDA) stock up nearly 400% since the beginning of 2015, it's easy to look back and regret not buying shares of the graphics-chip specialist. To be fair, NVIDIA's stellar growth has shocked even the most bullish analysts in recent quarters. The company has demonstrated bro
When Merck (MRK) claimed Gilead Sciences (GILD) had infringed on its patents in creating blockbuster hepatitis-C drugs Sovaldi and Harvoni, it asked for royalties of 10% of all sales. While the jury earlier this week found Merck’s patents to be valid, it determined that Gilead would have to pay just $200 million. Leerink’s Geoffrey Porges explains:
Most companies that have gone public this year are biotech firms and the first quarter marked the slowest start to IPOs since the last recession. In the current quarter, the fact that companies outside of biotech are eyeing or marching through the IPO door may be a sign of a slow thaw?
It doesn’t matter what Trump thinks or says. It matters what he does, and more importantly, what federal regulators do. Such is the patient suffering of AT&T (NYSE:T). Just what am I talking about here? WE learned today that allegedly Trump has expressed reservations and opposition to the AT&T and Time Warner (NYSE:TWX) deal. Supposedly Trump contended that the merger would concentrate....More>>>
Now that 2016 has come to an end, it is important to look forward and backwards for the new year. Many investment strategists have been issuing their top 2017 picks and favorites, and that was the same issue from Merrill Lynch to start the year. The firm issued 8 top picks with Buy ratings for the first quarter and most have an implied upside of 15% or more. Just keep in mind that some analyst price....More>>>
Is it time to speculate or to be cautious? I hope you've asked yourself that question. The answer gets to the heart of an important idea. It may shift the way you approach the markets… And it will allow you to recognize many more opportunities to profit in the coming year. Today, I'll show you how to do both – proceed with caution and speculate – safely.....More>>>
Gilead Sciences (GILD) posted better-than-expected fourth-quarter financial results as sales of its hepatitis C drugs exceeded forecasts. Still, the biotech giant gave back after-hour gains as full-year sales forecasts failed to impress.
Gilead also boosted its dividend and almost doubled its share repurchase plan.
At a recent $83, the shares were up 0.4% after earlier climbing more....More>>>
By now, it should be apparent to anybody with a functioning cerebellum that our political and economic policy leaders are abject failures. After years of impotent monetary policy at the hands of the Fed, decades of incompetent foreign policy by several administrations, a dormant and corrupt Congress, and an activist Supreme Court rewriting the Constitution, the world....More>>>
Palo Alto Networks (NYSE:PANW) is scheduled report FYQ4 results on 8/30, after the market close. After reading some of the publicly available earnings previews out there, which I think are highly dissatisfactory, I decided to write my own for the benefit of the retail investor. I hope this preview will help you gain more insight into the key debate points going into PANW’s earnings and also....More>>>
Yesterday, our Elite Opportunity Pronewsletter suggested large cap technical athletic apparel stock Lululemon Athletica inc (NASDAQ: LULU)as a speculative short trade:
I’m not going to dig deep into their financials, but trust me when I say we are not fans of Lululemon Athletica Inc. (LULU), The Kroger Co. (KR) and Nordstrom Inc. (JWN) right now I will say we used to like LULU, but....More>>>
Welcome to the latest issue of the PRO Weekly Digest. Every Saturday for Seeking Alpha PRO subscribers and Sunday for all other Seeking Alpha users, we publish highlights from our PRO coverage as well as feature interviews and other notable goings-on with SA PRO. Comment below or email us at
With the stock market now entering its ninth year of an epic bull run, and share prices at all-time highs, many investors are worried that dividend stocks, growth stocks — all stocks! — are trading at highly overvalued levels and set for a market crash.
The Q4 2016 earnings report forlarge cap luxury accessories stock Tiffany & Co (NYSE: TIF) is scheduled for before the market the opens onFriday (March 17th). Last month, JANA Partners LLC, which together with Francesco Trapani owns approximately 5.1% of Tiffany & Cos outstanding sha